Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Chromium and biotin play essential roles in regulating carbohydrate metabolism. This randomized, double‐blind, placebo‐controlled study evaluated the efficacy and safety of the combination of chromium picolinate and biotin on glycaemic control. Methods: Four hundred and forty‐seven subjects with poorly controlled type 2 diabetes (HbA 1c≥ 7.0%) were enrolled and received either chromium picolinate (600 µg Cr+3) with biotin (2 mg), or matching placebo, for 90 days in combination with stable oral anti‐diabetic agents (OADs). Major endpoints were reductions in HbA 1c, fasting glucose, and lipids. Safety and tolerability were assessed. Results: Change in HbA 1c was significantly different between treatment groups (p= 0.03). HbA 1c in the chromium picolinate/biotin group decreased 0.54%. The decrease in HbA 1c was most pronounced in chromium picolinate/biotin subjects whose baseline HbA 1c≥ 10%, and highly significant when compared with placebo (−1.76%vs− 0.68%;p= 0.005). Fasting glucose levels were reduced in the entire chromium picolinate/biotin group versus placebo (−9.8 mg/dL vs 0.7 mg/dL;p= 0.02). Reductions in fasting glucose were also most marked in those subjects whose baseline HbA 1c≥ 10.0%, and significant when compared to placebo (−35.8 mg/dL vs.16.2 mg/dL;p= 0.01). Treatment was well tolerated with no adverse effects dissimilar from placebo. Conclusions: These results suggest that the chromium picolinate/biotin combination, administered as an adjuvant to current prescription anti‐diabetic medication, can improve glycaemic control in overweight to obese individuals with type 2 diabetes; especially those patients with poor glycaemic control on oral therapy. Copyright © 2007 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes (type 2 DM) is increasing in the United States and worldwide [1].”
BackgroundKlaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235
Pharmacologic Therapy for Type 2 Diabetes Mellitus
DeFronzo, R. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00008 · Cited by 1,173
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Cellular chromium enhances activation of insulin receptor kinase
Wang, H., Kruszewski, A., & Brautigan, D. L. (2005) · Biochemistry · doi:10.1021/bi0473152 · Cited by 121 · cited 1×
“activity [59], as has been observed with other small”
Result
Cited by
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Wu, H., Tremaroli, V., Schmidt, C., Lundqvist, A., Olsson, L. M., Krämer, M., Gummesson, A., Perkins, R., Bergström, G., & Bäckhed, F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.011 · Cited by 528
The Malnutrition of Obesity: Micronutrient Deficiencies That Promote Diabetes
Via, M. (2012) · ISRN Endocrinology · doi:10.5402/2012/103472 · Cited by 297
Vanek, V. W., Borum, P., Buchman, A., Fessler, T. A., Howard, L., Jeejeebhoy, K., Kochevar, M., Shenkin, A., Valentine, C. J., Novel Nutrient Task Force, P. M. A. M. E. W. G., et al. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533612446706 · Cited by 293
Suksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12147 · Cited by 154
“Two others evaluated chromium plus biotin.(35,36) One trial evaluated chromium plus vitamins C and E.”
BackgroundInfluentialBelda, E., Voland, L., Tremaroli, V., Falony, G., Adriouch, S., Assmann, K. E., Prifti, E., Aron-Wisnewsky, J., Debédat, J., Le Roy, T., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325753 · Cited by 140
“Biotin supplementation was suggested to improve glucose metabolism in T2D subjects and in rodents, 18 21–23 and to impact adipose tissue metabolism.”
Background
Metadata
- Authors
- Albarracin, C. A., Fuqua, B. C., Evans, J. L., & Goldfine, I. D.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2007-05-16
- Volume
- 24
- Issue
- 1
- Pages
- 41-51
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W1969585124
- Cited by
- 128
- References
- 5
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.